For approval: look for a product record
As of October 1, 2026, a check of the FDA approval records found no ipamorelin medicine.
A code listing the material used to make a medicine does not show that the finished medicine has FDA approval.
Use the approval and ingredient records in the notes below when a claim points only to a code.
For benefit: read the study question
A hormone is a substance that sends signals inside the body.
The published ipamorelin studies in people found by October 1, 2026, concerned growth hormone release and recovery after bowel surgery.
The bowel-surgery study compared ipamorelin with a drip containing no ipamorelin. It measured how soon people could eat their first meal after surgery. That result and the other recovery results showed no clear difference between groups.
Ask whether the paper tests your goal. A rise in a hormone level does not by itself show that someone feels or functions better.
For missing results: leave the gap open
By October 1, 2026, no posted results or published paper had been found for the larger follow-up bowel-surgery trial.
A completed study is not a result. Ask for the actual findings rather than accepting the registry entry as proof.
For harm reports: keep cause separate
The FDA says a report of an unwanted event does not prove that the product caused it.
It also says those reports cannot be used to calculate how often an event happens.
Ask what the study actually tested and what it left unanswered. Ask whether it shows that the product caused the reported problem.